These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 25137428

  • 21. Update on the role of aromatase inhibitors in growth disorders.
    Dunkel L.
    Horm Res; 2009 Jan; 71 Suppl 1():57-63. PubMed ID: 19153508
    [Abstract] [Full Text] [Related]

  • 22. Treatment of delayed male puberty: efficacy of aromatase inhibition.
    Dunkel L, Wickman S.
    J Pediatr Endocrinol Metab; 2001 Jan; 14 Suppl 6():1541-6. PubMed ID: 11837512
    [Abstract] [Full Text] [Related]

  • 23. Novel treatment of delayed male puberty with aromatase inhibitors.
    Dunkel L, Wickman S.
    Horm Res; 2002 Jan; 57 Suppl 2():44-52. PubMed ID: 12065927
    [Abstract] [Full Text] [Related]

  • 24. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 25. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
    Mauras N, Bishop K, Merinbaum D, Emeribe U, Agbo F, Lowe E.
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2975-8. PubMed ID: 19470631
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adding Letrozole to Growth Hormone and Gonadotropin-Releasing Hormone Analog Increases Height in Girls With Short Stature: A Hospital Record-Based Retrospective Study.
    Li C, Wang X, Nie M, Mao J, Wu X.
    Endocr Pract; 2024 Jul; 30(7):639-646. PubMed ID: 38723894
    [Abstract] [Full Text] [Related]

  • 29. Letrozole as a booster therapy in growth hormone deficiency.
    Kumar KV, Jayaraman M, Verma A, Modi KD.
    Indian Pediatr; 2009 Jul; 46(7):625-7. PubMed ID: 19638662
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of P450 aromatase enhances gonadotropin secretion in early and midpubertal boys: evidence for a pituitary site of action of endogenous E.
    Wickman S, Dunkel L.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4887-94. PubMed ID: 11600558
    [Abstract] [Full Text] [Related]

  • 31. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
    Hero M, Toiviainen-Salo S, Wickman S, Mäkitie O, Dunkel L.
    J Bone Miner Res; 2010 Jul; 25(7):1536-43. PubMed ID: 20200972
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N.
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
    [Abstract] [Full Text] [Related]

  • 34. Use of aromatase inhibitors in children and adolescents: what's new?
    Diaz-Thomas A, Shulman D.
    Curr Opin Pediatr; 2010 Aug; 22(4):501-7. PubMed ID: 20489637
    [Abstract] [Full Text] [Related]

  • 35. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
    Leschek EW, Flor AC, Bryant JC, Jones JV, Barnes KM, Cutler GB.
    J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
    [Abstract] [Full Text] [Related]

  • 36. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S, Pirazzoli P, Baronio F, Gennari M, Bal MO, Balsamo A, Gualandi S, Cicognani A.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [Abstract] [Full Text] [Related]

  • 37. Cognitive effects of aromatase inhibitor therapy in peripubertal boys.
    Hero M, Maury S, Luotoniemi E, Service E, Dunkel L.
    Eur J Endocrinol; 2010 Jul; 163(1):149-55. PubMed ID: 20421333
    [Abstract] [Full Text] [Related]

  • 38. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
    Wickman S, Saukkonen T, Dunkel L.
    Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
    [Abstract] [Full Text] [Related]

  • 39. Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency.
    Akın Kağızmanlı G, Özalp Kızılay D, Besci Ö, Yüksek Acinikli K, Özen S, Demir K, Gökşen Şimşek RD, Böber E, Darcan Ş, Abacı A.
    J Endocrinol Invest; 2024 May; 47(5):1227-1235. PubMed ID: 38040920
    [Abstract] [Full Text] [Related]

  • 40. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.